In the email Leo says:
"It is important to note this and then you will understand that we are quite pleased with the results to date and expect the next few cohorts to give a clear answer to your question."
Was he referring to the fact that CLVS did part of their trial in Europe? OR
Was he referring to the fact that CLVS is targeting a very specific cancer type and have patients who are not terminal?
I'm guessing he is referring to the terminal patient issue and how truly sick these folks are.
Source - Read More: http://investorshangout.com/post/newpost/8737...z2VHSrvFF0